Drug intelligence / Profile preview

Runfei Huahe Paste

Development stage: Unknown
Lead developer: Jiangsu Tiansheng Pharmaceutical
Administration: Oral

Overview

Runfei Huahe Paste (润肺化核膏) is a traditional Chinese medicine (TCM) oral formulation developed and manufactured by Jiangsu Tiansheng Pharmaceutical. It is indicated for the treatment of pulmonary conditions and tuberculosis nodes (scrofula). As a 'gao' (paste) formulation, it is designed to moisten the lungs and resolve nodules or 'kernels' according to traditional Chinese therapeutic principles. The product is currently approved and marketed in China as a therapeutic or health-supporting formulation for respiratory and lymphatic health related to tubercular infections.

Brand names: 润肺化核膏Runfei Huahe Paste
Other names: Runfei Huahe Gao

Beyond the preview

Go deeper on Runfei Huahe Paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Runfei Huahe Paste.

Explore the full profile